SEC Comment Letter 0000000000-23-005046 to BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: May 12, 2023 · CIK: 0000811240 · Accession: 0000000000-23-005046
AI Filing Summary & Sentiment
File numbers found in text: 333-271660
Letter
United States securities and exchange commission logo May 12, 2023 John R. Beaver President and Chief Executive Officer BIOLASE, INC 27042 Towne Centre Drive, Suite 270 Lake Forest, California 92610 Re:BIOLASE, INC Registration Statement on Form S-1 Filed May 4, 2023 File No. 333-271660 Dear John R. Beaver: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Patrick Egan, Esq.
Show Raw Text
United States securities and exchange commission logo
May 12, 2023
John R. Beaver
President and Chief Executive Officer
BIOLASE, INC
27042 Towne Centre Drive, Suite 270
Lake Forest, California 92610
Re:BIOLASE, INC
Registration Statement on Form S-1
Filed May 4, 2023
File No. 333-271660
Dear John R. Beaver:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Schwartz at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Patrick Egan, Esq.